@Hawkbar33 @Taureanbull
These are supply agreements inked back in 2021/2022 for the Hervaxx and Pd-L1 trials.
Merck was for supply with Neo Herizon trial.
and Roche was for Tenxentriq in their PD! vaxx NSCLC trial.
As you know these trials are deprioritised/or completed.
This has nothing to do upcoming trials and supply required, I presume Imugene is supplying its own virus for any upcoming AzerCel/Vaccinia/Oncar
https://www.listcorp.com/asx/imu/imugene/news/clinical-trial-supply-agreement-with-merck-kgaa-and-pfizer-2630765.html
https://www.listcorp.com/asx/imu/imugene/news/pd1-vaxx-clinical-trial-supply-agreement-with-roche-2661954.html
@Hawkbar33 @TaureanbullThese are supply agreements inked back in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $179.4K | 14.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 15731879 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3463196 | 20 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |